NTBLQ (Notable Labs) Operating Cash Flow per Share : $-0.79 (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Operating Cash Flow per Share?

Notable Labs's operating cash flow per share for the three months ended in Jun. 2024 was $-0.39. Notable Labs's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.79.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Notable Labs's Operating Cash Flow per Share or its related term are showing as below:

NTBLQ's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.1
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Notable Labs Operating Cash Flow per Share Historical Data

The historical data trend for Notable Labs's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Operating Cash Flow per Share Chart

Notable Labs Annual Data

Trend

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-1.69

-1.30

-4.15

Notable Labs Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial			-0.33	-0.33	-	-0.40	-0.39

Competitive Comparison of Notable Labs's Operating Cash Flow per Share

For the Biotechnology subindustry, Notable Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Notable Labs's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Notable Labs Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Notable Labs's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-13.716	/	3.303
	=	-4.15

Notable Labs's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-3.71	/	9.456
	=	-0.39

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.79

Notable Labs Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Notable Labs's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Hatch Drive, Foster City, CA, USA, 94404

Website

https://notablelabs.com

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.